We are live on ! Find out more
Nicholas Company

Nicholas Company Portfolio holdings

AUM $5.47B Turnover 6.8%
1-Year Est. Return 16.96%
This Fund
S&P 500
This Quarter Est. Return
-8.88%
1 Year Est. Return
+16.96%
3 Year Est. Return
+65.72%
5 Year Est. Return
+94.16%
10 Year Est. Return
+404.17%
AUM
$5.28B
AUM Growth
-$439M
Cap. Flow
+$136M
Cap. Flow %
2.58%
Top 10 Hldgs %
29.74%
Holding
225
New
9
Increased
53
Reduced
115
Closed
11
Avg Time Held
1.8 years
Top 10 Avg Time Held
1.6 years
Top 20 Avg Time Held
1.3 years

Top Buys

Rank Stock Value
1
T icon
AT&T
T
+$61.9M
2
TWX
Time Warner Inc
TWX
+$54.9M
3
PAGP icon
Plains GP Holdings
PAGP
+$31.5M
4
PARA icon
Paramount Global Class B
PARA
+$27M
5
CAB
Cabela's Inc
CAB
+$19.5M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.7M
2
SLH
SOLERA HOLDINGS, INC. COM
SLH
+$60.1M
3
SYNT
Syntel Inc
SYNT
+$24.6M
4
ALSN icon
Allison Transmission
ALSN
+$9.6M
5
NUS icon
Nu Skin
NUS
+$9.1M

Sector Composition

Rank Sector Weight
1 Healthcare 28.09%
2 Industrials 18.97%
3 Consumer Discretionary 15.9%
4 Financials 10.46%
5 Communication Services 8.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BHC icon
1
Bausch Health
BHC
$2.2B
$245M 4.64%
1,372,490
-23,410
-2% -$5.46M
2013 Q2
9 quarters
GILD icon
2
Gilead Sciences
GILD
$190B
$206M 3.9%
2,094,525
+8,250
+0.4% +$916K
2013 Q2
9 quarters
WBA icon
3
DELISTED
Walgreens Boots Alliance
WBA
$186M 3.53%
2,243,425
-17,110
-0.8% -$1.55M
2013 Q2
9 quarters
ORLY icon
4
O'Reilly Automotive
ORLY
$70.1B
$153M 2.9%
9,186,855
-75
-0% -$1.21K
2013 Q2
9 quarters
AMG icon
5
Affiliated Managers Group
AMG
$9.62B
$143M 2.71%
837,060
+25,630
+3% +$5.04M
2013 Q2
9 quarters
SNA icon
6
Snap-on
SNA
$18.8B
$142M 2.69%
940,175
-2,205
-0.2% -$354K
2013 Q2
9 quarters
LKQ icon
7
LKQ Corp
LKQ
$5.52B
$129M 2.44%
4,535,407
-10,700
-0.2% -$326K
2013 Q2
9 quarters
TMO icon
8
Thermo Fisher Scientific
TMO
$249B
$124M 2.35%
1,013,659
-96
-0% -$12.5K
2013 Q2
9 quarters
UHAL icon
9
U-Haul Holding Co
UHAL
$10.9B
$124M 2.34%
3,138,870
+20,000
+0.6% +$727K
2014 Q2
5 quarters
T icon
10
AT&T
T
$158B
$118M 2.24%
4,810,734
+2,425,687
+102% +$61.9M
2013 Q2
9 quarters
AON icon
11
Aon
AON
$58.4B
$118M 2.23%
1,328,090
-5,815
-0.4% -$563K
2013 Q2
9 quarters
TWX
12
DELISTED
Time Warner Inc
TWX
$117M 2.22%
1,707,310
+698,640
+69% +$54.9M
2013 Q2
9 quarters
CB icon
13
Chubb
CB
$135B
$116M 2.2%
1,121,990
+167,755
+18% +$17.5M
2014 Q1
6 quarters
ADT icon
14
DELISTED
ADT Corp
ADT
$110M 2.09%
3,684,730
+331,125
+10% +$10.7M
2014 Q2
5 quarters
MSFT icon
15
Microsoft
MSFT
$3.96T
$110M 2.08%
2,476,445
-8,640
-0.3% -$388K
2013 Q2
9 quarters
KMI icon
16
Kinder Morgan
KMI
$74.3B
$110M 2.08%
3,958,058
+393,639
+11% +$13M
2013 Q2
9 quarters
PAGP icon
17
Plains GP Holdings
PAGP
$5.37B
$102M 1.93%
2,180,192
+563,545
+35% +$31.5M
2015 Q1
2 quarters
JCI icon
18
Johnson Controls International
JCI
$92.3B
$97.7M 1.85%
2,256,417
+355,165
+19% +$16.4M
2013 Q4
7 quarters
CBRE icon
19
CBRE Group
CBRE
$37.3B
$95.5M 1.81%
2,984,585
+4,565
+0.2% +$162K
2013 Q2
9 quarters
ABBV icon
20
AbbVie
ABBV
$501B
$94.1M 1.78%
1,729,170
+22,525
+1% +$1.47M
2015 Q1
2 quarters
BALL icon
21
Ball Corp
BALL
$16B
$93.4M 1.77%
3,003,132
-44,830
-1% -$1.52M
2013 Q2
9 quarters
PM icon
22
Philip Morris
PM
$320B
$93M 1.76%
1,172,605
+50,000
+4% +$4.12M
2013 Q2
9 quarters
PFE icon
23
Pfizer
PFE
$166B
$92.5M 1.75%
3,104,826
+96,278
+3% +$3.09M
2013 Q2
9 quarters
DVA icon
24
DaVita
DVA
$11.5B
$90.6M 1.72%
1,252,553
-215
-0% -$16.7K
2013 Q2
9 quarters
PCP
25
DELISTED
PRECISION CASTPARTS CORP
PCP
$88.5M 1.68%
385,375
– –
2014 Q4
3 quarters
1
2 3 4 5

Similar funds

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
EFG International
EFG International Zurich $5.46B AUM
Antipodes Partners
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Exor N.V.
Exor N.V. Amsterdam, Netherlands $5.46B AUM 6.21% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Voleon Capital Management
Voleon Capital Management Berkeley, California $5.49B AUM 56.94% 1-Year Est. Return
Glenview Capital Management
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
TD Private Client Wealth
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return

Nicholas Company's Q3 2015 Portfolio in Review

As of Q3 2015, Nicholas Company held 225 positions worth $5.28B, down 7.7% from $5.72B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Nicholas Company's Q3 2015 filing shows 9 new, 53 increased, 115 reduced and 11 closed positions. Its largest new stake was Paramount Global Class B: 556,735 shares worth $22.2M. The largest sale was CR Bard Inc., an estimated $62.7M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 30% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Nicholas Company's largest Q3 2015 buy was Paramount Global Class B: 556,735 shares worth $22.2M.
  • Nicholas Company added most to AT&T in Q3 2015, an estimated $61.9M increase.
  • Nicholas Company's biggest Q3 2015 reduction was CR Bard Inc., cutting an estimated $62.7M.
  • Nicholas Company fully exited Nu Skin in Q3 2015, selling an estimated $9.1M.
  • Nicholas Company's ten largest holdings make up 30% of its $5.28B portfolio in Q3 2015.
  • Nicholas Company opened 9 new positions and closed 11 in Q3 2015.
  • Nicholas Company's portfolio value fell 7.7% quarter-over-quarter to $5.28B.

Based on Nicholas Company's 13F filing for Q3 2015, filed 12 Nov 2015.